Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Total Non-Current Liabilities (2022 - 2026)

Axsome Therapeutics' Total Non-Current Liabilities history spans 5 years, with the latest figure at $585.3 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 29.24% to $585.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $585.3 million, a 29.24% increase, with the full-year FY2025 number at $524.0 million, up 24.81% from a year prior.
  • Total Non-Current Liabilities hit $585.3 million in Q1 2026 for Axsome Therapeutics, up from $524.0 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for AXSM hit a ceiling of $585.3 million in Q1 2026 and a floor of $136.0 million in Q2 2022.
  • Historically, Total Non-Current Liabilities has averaged $357.5 million across 5 years, with a median of $353.7 million in 2024.
  • Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 120.05% in 2023 and later rose 24.81% in 2025.
  • Tracing AXSM's Total Non-Current Liabilities over 5 years: stood at $190.8 million in 2022, then skyrocketed by 69.77% to $324.0 million in 2023, then rose by 29.59% to $419.8 million in 2024, then rose by 24.81% to $524.0 million in 2025, then rose by 11.7% to $585.3 million in 2026.
  • Business Quant data shows Total Non-Current Liabilities for AXSM at $585.3 million in Q1 2026, $524.0 million in Q4 2025, and $505.7 million in Q3 2025.